• NEW
  • IVD
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 2
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 3
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 4
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 5
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 2
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 3
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 4
  • ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit - Picture 5

ImmunoIVD SPOT-it TREC, KREC & SMN1 Screening Kit

Manufacturer:ImmunoIVD
Country:Sweden

Specialist consultation

+38 (067) 880 44 83

Details

SPOT-it™ TREC, KREC & SMN1 Screening Kit is an in vitro diagnostic kit intended for simultaneous screening for severe combined immunodeficiency (SCID), agammaglobulinemia (XLA) and Spinal Muscular Atrophy (SMA) in newborns.

 

Screening for SCID and XLA is performed by semi-quantification of T-cell receptor excision circle (TREC) and kappa-deleting recombination excision circles (KREC) and SMA screening by a qualitative detection of exon 7 of the SMN1 gene. DNA is extracted from fresh, dried blood spots (DBS) sampled on filter paper. The principle of the assay is real-time quantitative polymerase chain reaction (qPCR).

 

The test is intended for use by laboratory professionals to aid in identifying newborns who potentially suffer from SCID caused by a lack of mature T- or T and B-lymphocytes or XLA caused by a selective lack of mature B-lymphocytes or SMA caused by homozygous exon 7 deletion in the SMN1 gene. Diagnosis shall be made by healthcare professionals through confirmatory testing, according to local requirements or recommendations.

 

Quick Assay Information

Complete solution for SCID, XLA and SMA screening including DNA extraction

From Dried Blood Spot (DBS) to screening result within 3 hours

Ready-to-use plates pre-filled with reaction mix and samples to generate a standard curve

Just two pipetting steps for quick and easy handling

Uses conventional 3.2 mm DBS as input

Designed for the needs of screening laboratories CE marked  For In Vitro Diagnostic (IVD) use in EU

 

How it works

 

1 Sample distribution

Dried Blood Spot (DBS) samples are punched into SPOT-it™ filter plate.

 

2 Rinse DBS

Samples are rinsed and rehydrated to remove hemoglobin and other impurities.

 

3 DNA Elution

DNA is eluted by heating to 95 °C for 30 minutes.

 

4 qPCR

TREC, KREC and ACTB copies are quantified and SMN1 detected using qPCR.

 

 

 

Product Details

Product name: SPOT-it™ TREC, KREC & SMN1 Screening Kit

Description: Newborn screening for SCID, XLA & SMA

 

Product Code

Format

Samples per kit

4-2020-TKS

4 x 96-well plate

324

12-2020-TKS

12 x 96-well plates

972

 

Characteristics

Type of analysisQuantitative / qualitative
TargetTREC, ACTB, SMN1, KREC
Number of tests324 / 972
Specifity of the analysis100%
Regulatory statusCE IVD
Detection channelsFAM, Cy5, TAMRA, VIC, ROX
Sensitivity of the analysis100%
SoftwareSPOT-it Analysis Software

Service and Warranty

We provide premium service and maintenance for every device and consumable:

 

Comprehensive maintenance of medical equipment

Installations, commissioning

Warranty and post-warranty service

Instruction, training and consultations for your team

 

More details on the SERVICE page

Contact phone+38 (067) 120 95 75
E-mail:service@empirica.healthcare